Intrapartum Monitoring Devices Market Projected to Reach $2.3 Billion by 2023
[London, United Kingdom] – [1st June 2023] – The global intrapartum monitoring devices market is projected to reach $2.3 billion by 2023, according to a new report by Pharmanucleus. The market is being driven by the increasing incidence of preterm births, the rising demand for maternal and fetal care devices, and the growing adoption of wireless monitoring technologies.
Intrapartum monitoring devices are used to track the fetal heart rate and uterine contractions during labor. These devices can help to identify potential problems early on and provide clinicians with the information they need to make informed decisions about care.
The global intrapartum monitoring devices market is segmented by product type, method, end user, and region. By product type, the market is segmented into monitors, electrodes, and software. By method, the market is segmented into invasive and non-invasive. By end user, the market is segmented into hospitals, clinics, and home healthcare. By region, the market is segmented into North America, Europe, Asia Pacific, and Rest of the World.
North America is the largest market for intrapartum monitoring devices, followed by Europe and Asia Pacific. The large market share of North America is attributed to the high prevalence of preterm births, the increasing demand for maternal and fetal care devices, and the presence of a large number of well-established players in the market.
The Asia Pacific market is expected to grow at the fastest rate during the forecast period, due to the rising awareness about the importance of maternal and fetal health, the increasing number of births in the region, and the growing adoption of wireless monitoring technologies.
The key players in the global intrapartum monitoring devices market include Koninklijke Philips N.V., Medtronic plc., CooperSurgical, Inc., GE Healthcare, and Analogic Corporation. These players are focusing on product innovation, geographic expansion, and mergers and acquisitions to gain a competitive edge in the market.
For more information about the report and to request a sample copy, please visit?
Contact Us:
John.M
Business Consultant
john.m@pharmanucleus.com
Support: +44 (0)20 8470 4967
https://www.pharmanucleus.com/
About Pharmanucleus
Pharma Nucleus is a market research company that provides clients access to custom, syndicated reports and consulting on one platform. As a company with rich knowledge in analysis and research across healthcare domains, such as pharma, medical device and biotechnology. Insights derived from Pharma Nucleus help life sciences and other healthcare organizations accelerate the launch, development, and dissemination of life-saving therapies, navigate significant attention with key opinion leaders, and help ensure equitable access to healthcare services.